Starling Fluid Management Monitoring System
ADVANCING PERSONALISED FLUID MANAGEMENT
Offering a fully non-invasive and precise central-flow-based approach to fluid management, the Starling Fluid Management Monitoring System is part of Baxter’s market-leading innovation in medication delivery. The Starling system advances efforts to shift treatment away from a one-size-fits-all approach towards individualised, patient-specific treatment decisions to help clinicians deliver the right therapy to the right patient at the right time.
100% NON-INVASIVE FLUID MANAGEMENT
The Starling system empowers clinicians with an accurate,1 reliable and 100% non-invasive fluid management technology to aid in administering the right intervention at the appropriate time.
Assessing whether fluid may help or harm a patient is a critical step in optimising treatment. The Starling system provides a full haemodynamic profile within seconds to deliver meaningful insights that drive real-time clinical decision-making. The system can be used across the continuum of care, which includes emergency department, intensive care unit, operating room and rapid response team scenarios.2-4
FLEXIBLE, ACCURATE TECHNOLOGY MEETS A DYNAMIC CLINICAL NEED1
Healthcare professionals know that every patient has unique and constantly changing fluid management needs. Yet fluid monitoring technology has traditionally not provided the flexibility and rapid accuracy needed to account for these dynamic needs.
Using patented Bioreactance technology, the Starling system represents the latest advancements in haemodynamic monitoring, providing easy-to-use, non-invasive central-flow-based technology that delivers accurate and precise data to take the guesswork out of fluid management.1
ENHANCING CLINICAL AND ECONOMIC OUTCOMES
Proper fluid management may improve clinical outcomes and help reduce costs.5-8 Published data demonstrate the Starling system’s positive impact on improved patient outcomes and associated reductions in cost of care.5,7,8
AN EXTENSIVELY VALIDATED TECHNOLOGY
-
100+ peer-reviewed publications
-
Multiple clinical settings where patients require fluids, including medical and surgical intensive care units, emergency departments and operating rooms2-4
-
Comparative analyses against all major technologies, including Swan-Ganz, Pulse Contour, Doppler and Fick9-12
SV STARLING Monitor — Non-invasive haemodynamic monitoring system.
Intended purpose: The Starling SV system, with NIBP and SpO2 functionality, is intended for professional use in healthcare facilities. It is a portable non-invasive haemodynamic cardiac output monitor. It monitors and displays a patient's cardiac output (CO) in l/min with a non-invasive blood pressure (NIBP) function that non-invasively measures and displays blood pressure (diastolic, systolic and mean) and heart rate, and an SpO2 function that non-invasively measures and displays blood oxygen saturation (SpO2). The device displays the corresponding haemodynamic parameters based on measurements or measurement calculations already incorporated in the Starling SV.
Class IIa device. Notified body: MEDCERT - Germany (CE 0482).
Please refer to the instructions for use for information necessary for proper use.
Carefully read the instructions in the package insert.
Date of revision: 31 March 2020.
Baxter, Starling and Bioreactance are trademarks of Baxter International Inc. or its subsidiaries